Evidence map›Paper›PMID 31963160›Full record

ArticleInternational journal of molecular sciences2020

The Impact of IPTG Induction on Plasmid Stability and Heterologous Protein Expression by

Luciana Gomes, Gabriel Monteiro, Filipe Mergulhão

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 57 citations in OpenAlex.

  1. Article
  2. Article
  3. Metabolic engineering ofBiodesign research · 2025
    Article
  4. Article
  5. Construction of antibiotic-free riboflavin producer inSynthetic and systems biotechnology · 2025
    Article
  6. EngineeringMolecules (Basel, Switzerland) · 2025
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Frontiers in bioengineering and biotechnology · 2023
    Article
  15. Review
  16. Article
  17. Article
  18. Customized chitooligosaccharide production-controlling their lengthFrontiers in bioengineering and biotechnology · 2022
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Luciana GomesLEPABE-Department of Chemical Engineering, Faculty of Engineering, University of Porto, 4200-465 Porto, Portugal.ORCID 0000-0002-8992-1097
Gabriel MonteiroiBB-Institute for Bioengineering and Biosciences, Department of Bioengineering, Instituto Superior Técnico, Universidade de Lisboa, 1049-001 Lisboa, Portugal.
Filipe MergulhãoLEPABE-Department of Chemical Engineering, Faculty of Engineering, University of Porto, 4200-465 Porto, Portugal.ORCID 0000-0001-5233-1037
Universidade do Porto · PTUniversity of Lisbon · PT

Funding

Fundação para a Ciência e a Tecnologia CEECIND/01700/2017Fundação para a Ciência e a Tecnologia LEPABE - Laboratório de Engenharia de Processos, Ambiente, Biotecnologia e Energia - UID/EQU/00511Programa Operacional Temático Factores de Competitividade POCI-01-0145-FEDER-029589
6 · The paper itself

Abstract

This work assesses the effect of chemical induction with isopropyl β-D-1-thiogalactopyranoside (IPTG) on the expression of enhanced green fluorescent protein (eGFP) by planktonic and biofilm cells of

Indexed as

BiofilmsEscherichia coliEscherichia coli ProteinsGreen Fluorescent ProteinsIsopropyl ThiogalactosidePlasmidsPromoter Regions, Geneticenhanced green fluorescent proteinEscherichia coli ProteinsGreen Fluorescent ProteinsIsopropyl ThiogalactosidebiofilmEscherichia coliheterologous protein expressionIPTGplasmid copy numberplasmid stability

Identifiers

PMID31963160
PMCPMC7013871
OpenAlexW3000427808

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.